It certainly seems like we have drifted away from what i thought was our last stated target, ie blood burne cancers. I think that is a good thing as we should be targetting at least 50 50 fpp applications and cancer/ myc oncology. Will be interesting to see if any developments with genentech when another year goes by in Dec. If they do anything to extend or license that could be a major boost without anything else? I assume any new milestone may be same as or bigger than last, and another 2 mil certainly wouldnt hurt on top of current funding with no dilution.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.040(3.23%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $79.39K | 62.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23727 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 1942 | 1 |
View Market Depth
| Last trade - 14.40pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |